A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma

NCT03514407 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic Business Decision

Conditions

Relapsed Ewing Sarcoma

Interventions

DRUG: INCB059872

Sponsor

Incyte Corporation